Allspring Global Investments
MRVI icon

Allspring Global Investments’s Maravai LifeSciences MRVI Stock Holding History

Allspring Global Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,103
Closed -$9.16K – 2159
2024
Q3 		$9.16K Buy
1,103
+166
+18% +$1.44K ﹤0.01% 2102
2024
Q2 		$6.71K Buy
+937
New +$8.09K ﹤0.01% 2213
2024
Q1 		– Sell
-81
Closed -$530 – 2360
2023
Q4 		$530 Sell
81
-1,434
-95% -$9.26K ﹤0.01% 2157
2023
Q3 		$15.2K Buy
1,515
+198
+15% +$2.17K ﹤0.01% 2558
2023
Q2 		$16.4K Sell
1,317
-194
-13% -$2.62K ﹤0.01% 2490
2023
Q1 		$21.2K Hold
1,511
– – ﹤0.01% 2492
2022
Q4 		$21.6K Sell
1,511
-79,614
-98% -$1.25M ﹤0.01% 2573
2022
Q3 		$2.07M Sell
81,125
-108,085
-57% -$2.71M ﹤0.01% 1223
2022
Q2 		$5.38M Sell
189,210
-2,999
-2% -$95K 0.01% 967
2022
Q1 		$6.78M Sell
192,209
-491,708
-72% -$16.5M 0.01% 1024
2021
Q4 		$28.7M Buy
+683,917
New +$27.7M 0.03% 597

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allspring Global Investments's MRVI Position: Q4 2024 in Review

Allspring Global Investments sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 1,103 shares — an estimated $9.16K sold.

Allspring Global Investments first reported a position in MRVI in Q4 2021 and held it in 11 quarters. The position peaked at $28.7M in Q4 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • Allspring Global Investments reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 1,103 Maravai LifeSciences shares in Q4 2024, an estimated $9.16K.
  • Allspring Global Investments first reported a position in Maravai LifeSciences in Q4 2021 and held it in 11 quarters.
  • Allspring Global Investments's Maravai LifeSciences position peaked at $28.7M in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.